Medication guidelines

Sanjay Kalra, Diabetologist and Editorial Board member, outlines what's new in the American Diabetes Association’s 2020 Standards of Care update [read more].

Diabetologist Amar Puttanna addresses growing concerns about the rise of dementia in diabetes care and highlights where guidelines, research efforts, and management options are needed to tackle this comorbidity [read more].

Get more on: Mental health and diabetes | Diabetes complications and comorbidities | Diabetes in older adults

Carmen Soto and David Strain provide their insights on clinical inertia in diabetes care and present the co-production model of open communication as an innovative means to address this widespread clinical issue [read more].

Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles [read more].

Get more on: Medications | Type 1 diabetes | Type 2 diabetes

Diabetes and endocrinology Consultant and Advisory Board member Terence Pang highlights the benefits that a structured approach to glycemic goal setting can bring to your practice and patients with type 1 diabetes [read more].

Get more on: Type 1 diabetes | Insulin | Glycemic control | Self-management

In the wake of the revised blood pressure targets, Editorial Board member Jay Shubrook and Advisory Board member Robert Chilton discuss clinical approaches to get hypertensive diabetes patients to target more consistently [watch the video 12:29].

Get more on: Anti-hypertensive medications | Cardiovascular disease complications | Type 1 diabetes | Type 2 diabetes

The drive to achieve lower HbA1c targets in older patients is not without concern or risk. Our UK Board address concerns highlighted by recent trials and discuss whether current guidelines do enough to mitigate the risks of overtreatment [read more].

Get more on: Medication | Older adults |  Type 2 diabetes

Editorial Board member Jay Shubrook and lead author on the American Diabetes Association’s (ADA) 2017 Position Statement on diabetes and hypertension, Ian de Boer, summarize key updates to the recommendations for practitioners in the United States [watch the video 11:32].

Get more on: Type 1 diabetes | Type 2 diabetes | Cardiovascular disease | Guidelines

Treating type 2 diabetes has become so complicated. Why is this so? Editorial Board member Jay Shubrook discusses the reasons and suggests ways to make diabetes treatment less overwhelming.

Get more on: Type 2 diabetes | Insulin | Hypoglycemia

What do the results of CVOTs mean for practicing clinicians? Medicine Matters contributor, Carol Wysham reviews the latest evidence and guidelines for reducing CV risk in patients with type 2 diabetes [read more].

Get more on: Diabetic complications | Medications | Type 2 diabetes